PainReform PRFX Stock
PainReform Price Chart
PainReform PRFX Financial and Trading Overview
| PainReform stock price | 2.23 USD |
| Previous Close | 0.51 USD |
| Open | 0.52 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1400 |
| Day's Range | 0.5 - 0.53 USD |
| 52 Week Range | 0.34 - 1.29 USD |
| Volume | 8.19K USD |
| Avg. Volume | 47.74K USD |
| Market Cap | 5.36M USD |
| Beta (5Y Monthly) | -0.203307 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -32.16 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3 USD |
PRFX Valuation Measures
| Enterprise Value | -2715035 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.64089745 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.6030157 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.283 |
Trading Information
PainReform Stock Price History
| Beta (5Y Monthly) | -0.203307 |
| 52-Week Change | -46.23% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.29 USD |
| 52 Week Low | 0.34 USD |
| 50-Day Moving Average | 0.58 USD |
| 200-Day Moving Average | 0.57 USD |
PRFX Share Statistics
| Avg. Volume (3 month) | 47.74K USD |
| Avg. Daily Volume (10-Days) | 21.26K USD |
| Shares Outstanding | 10.72M |
| Float | 5.96M |
| Short Ratio | 0.76 |
| % Held by Insiders | 8.02% |
| % Held by Institutions | 37.29% |
| Shares Short | 71.39K |
| Short % of Float | 0.97% |
| Short % of Shares Outstanding | 0.67% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.72% |
| Return on Equity (ttm) | -73.50% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -9598000 USD |
| Net Income Avi to Common (ttm) | -9406000 USD |
| Diluted EPS (ttm) | -0.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.14M USD |
| Total Cash Per Share (mrq) | 0.76 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.101 |
| Book Value Per Share (mrq) | 0.829 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7303000 USD |
| Levered Free Cash Flow (ttm) | -3887125 USD |
Profile of PainReform
| Country | United States |
| State | N/A |
| City | Tel Aviv |
| Address | 65 Yigal Alon Street |
| ZIP | 6745442 |
| Phone | 972 3 717 7050 |
| Website | https://www.painreform.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
Q&A For PainReform Stock
What is a current PRFX stock price?
PainReform PRFX stock price today per share is 2.23 USD.
How to purchase PainReform stock?
You can buy PRFX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PainReform?
The stock symbol or ticker of PainReform is PRFX.
Which industry does the PainReform company belong to?
The PainReform industry is Drug Manufacturers-Specialty & Generic.
How many shares does PainReform have in circulation?
The max supply of PainReform shares is 1.89M.
What is PainReform Price to Earnings Ratio (PE Ratio)?
PainReform PE Ratio is now.
What was PainReform earnings per share over the trailing 12 months (TTM)?
PainReform EPS is -32.16 USD over the trailing 12 months.
Which sector does the PainReform company belong to?
The PainReform sector is Healthcare.
PainReform PRFX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17146.39 USD — |
-1.36
|
6.49B USD — | 17133.29 USD — | 17467.35 USD — | — - | 6.49B USD — |
| NASDAQ HealthCare IXHC | 924.57 USD — |
+0.11
|
— — | 923.44 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}